Collaboration is a huge topic in healthcare today. The industry is evolving extremely fast, and while that brings with it plenty of opportunity, it also creates new challenges.
With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.